These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 18396368)

  • 1. Erythropoietin: elucidating new cellular targets that broaden therapeutic strategies.
    Maiese K; Chong ZZ; Li F; Shang YC
    Prog Neurobiol; 2008 Jun; 85(2):194-213. PubMed ID: 18396368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raves and risks for erythropoietin.
    Maiese K; Chong ZZ; Shang YC
    Cytokine Growth Factor Rev; 2008 Apr; 19(2):145-55. PubMed ID: 18299246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erythropoietin and the nervous system.
    Genc S; Koroglu TF; Genc K
    Brain Res; 2004 Mar; 1000(1-2):19-31. PubMed ID: 15053948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythropoietin on a tightrope: balancing neuronal and vascular protection between intrinsic and extrinsic pathways.
    Li F; Chong ZZ; Maiese K
    Neurosignals; 2004; 13(6):265-89. PubMed ID: 15627815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New avenues of exploration for erythropoietin.
    Maiese K; Li F; Chong ZZ
    JAMA; 2005 Jan; 293(1):90-5. PubMed ID: 15632341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The brain erythropoietin system and its potential for therapeutic exploitation in brain disease.
    Hasselblatt M; Ehrenreich H; Sirén AL
    J Neurosurg Anesthesiol; 2006 Apr; 18(2):132-8. PubMed ID: 16628067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythropoietin (epoetin) as a protective factor for the brain.
    Malhotra S; Nijhawan S; Rosenbaum DM
    Curr Atheroscler Rep; 2004 Jul; 6(4):301-6. PubMed ID: 15191705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin requires NF-kappaB and its nuclear translocation to prevent early and late apoptotic neuronal injury during beta-amyloid toxicity.
    Chong ZZ; Li F; Maiese K
    Curr Neurovasc Res; 2005 Dec; 2(5):387-99. PubMed ID: 16375720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin as a novel neuroprotectant.
    Genc S; Koroglu TF; Genc K
    Restor Neurol Neurosci; 2004; 22(2):105-19. PubMed ID: 15272145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic strategy of erythropoietin in neurological disorders.
    Liu XB; Wang JA; Yu SP; Keogh CL; Wei L
    CNS Neurol Disord Drug Targets; 2008 Jun; 7(3):227-34. PubMed ID: 18673207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin: a hormone with multiple functions.
    Lombardero M; Kovacs K; Scheithauer BW
    Pathobiology; 2011; 78(1):41-53. PubMed ID: 21474975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain protection by erythropoietin: a manifold task.
    Rabie T; Marti HH
    Physiology (Bethesda); 2008 Oct; 23():263-74. PubMed ID: 18927202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of erythropoietin on brain function.
    Jelkmann W
    Curr Pharm Biotechnol; 2005 Feb; 6(1):65-79. PubMed ID: 15727557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythropoietin: new directions for the nervous system.
    Maiese K; Chong ZZ; Shang YC; Wang S
    Int J Mol Sci; 2012; 13(9):11102-11129. PubMed ID: 23109841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin in the brain: can the promise to protect be fulfilled?
    Maiese K; Li F; Chong ZZ
    Trends Pharmacol Sci; 2004 Nov; 25(11):577-83. PubMed ID: 15491780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extra-hematopoietic effects of erythropoietin.
    Cariou A; André S; Claessens YE
    Cardiovasc Hematol Disord Drug Targets; 2008 Sep; 8(3):173-8. PubMed ID: 18781929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pleiotropic effects of erythropoietin in the central nervous system.
    Buemi M; Cavallaro E; Floccari F; Sturiale A; Aloisi C; Trimarchi M; Corica F; Frisina N
    J Neuropathol Exp Neurol; 2003 Mar; 62(3):228-36. PubMed ID: 12638727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revisiting the role of erythropoietin for treatment of ocular disorders.
    Shirley Ding SL; Leow SN; Munisvaradass R; Koh EH; Bastion ML; Then KY; Kumar S; Mok PL
    Eye (Lond); 2016 Oct; 30(10):1293-1309. PubMed ID: 27285322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanisms of protective action of erythropoietin in cells].
    Borysewicz-Sańczyk H; Szczepański M
    Pol Merkur Lekarski; 2011 Jan; 30(175):56-61. PubMed ID: 21542247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress: Biomarkers and novel therapeutic pathways.
    Maiese K; Chong ZZ; Hou J; Shang YC
    Exp Gerontol; 2010 Mar; 45(3):217-34. PubMed ID: 20064603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.